Skip to main content
Jaishri Blakeley, MD, Neurology, Baltimore, MD, Johns Hopkins Hospital

JaishriO'neillBlakeleyMD

Neurology Baltimore, MD

Neurooncology

Professor of Neurology, Professor of Neurological Surgery, Professor of Oncology, Johns Hopkins University School of Medicine; Director, The Johns Hopkins Comprehensive Neurofibromatosis Center; Director, neurofibromatosis therapeutic acceleration program

Dr. Blakeley is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Blakeley's full profile

Already have an account?

  • Office

    600 N. Wolfe Street
    Cancer Research Building II 1M16
    Baltimore, MD 21287
    Phone+1 410-502-6732
    Fax+1 410-614-9335
  • Is this information wrong?

Summary

  • Dr. Jaishri Blakeley is a neurologist in Baltimore, MD and is affiliated with multiple hospitals in the area, including Johns Hopkins Hospital and Johns Hopkins Bayview Medical Center. She received her medical degree from Baylor College of Medicine and has been in practice 16 years. She specializes in neurooncology and is experienced in neurofibromatosis, neuro-oncology, gliomas, drug delivery systems, and clinical trials.

Education & Training

  • Johns Hopkins University
    Johns Hopkins UniversityResidency, Neurology, 2002 - 2005
  • Baylor College of Medicine
    Baylor College of MedicineInternship, Internal Medicine, 2001 - 2002
  • Baylor College of Medicine
    Baylor College of MedicineClass of 2001

Certifications & Licensure

  • MD State Medical License
    MD State Medical License 2006 - 2024
  • NC State Medical License
    NC State Medical License 2020 - 2022
  • American Board of Psychiatry and Neurology Neurology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013-2014

Clinical Trials

Publications & Presentations

PubMed

Lectures

  • Familial Unilateral Vestibular Schwannoma Is Rarely Caused by Inherited Variants in the NF2 Gene 
    ASCO Annual Meeting 2019 - Chicago, IL - 6/4/2019

Press Mentions

  • Bringing Brigatinib to Neurofibromatosis Type-2 Patients: From Promising Potential to Platform Clinical Trial
    Bringing Brigatinib to Neurofibromatosis Type-2 Patients: From Promising Potential to Platform Clinical TrialMay 29th, 2020
  • Health Beat: NF Tumors: Hearing Can Be Restored
    Health Beat: NF Tumors: Hearing Can Be RestoredSeptember 21st, 2016
  • Anticancer Drug Restores Hearing in Some Patients with Neurofibromatosis
    Anticancer Drug Restores Hearing in Some Patients with NeurofibromatosisMarch 14th, 2016

Professional Memberships

Hospital Affiliations